Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 4.9B | 5.1B | 5.1B | -1.7B |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | 1.7B | 1.7B | 1.7B | 1.7B |
| Other operating expenses | — | — | — | — |
| Operating income | — | — | — | — |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | — | — | — | — |
| Other income expense | — | — | — | — |
| Pretax income | 1.5B | 1.6B | 1.7B | -5.2B |
| Tax provision | 274M | 265M | 271M | -1.3B |
| Net income | 1.3B | 1.3B | 1.4B | 922M |
| Basic EPS | 0.9 | 0.9 | 1 | 0.6 |
| Diluted EPS | 0.9 | 0.9 | 1.0 | 0.6 |
| Basic average shares | 1.3B | 1.3B | 1.3B | 1.3B |
| Diluted average shares | 1.3B | 1.3B | 1.3B | 1.3B |
| EBITDA | — | — | — | — |
| Net income from continuing op. | 1.3B | 1.3B | 1.4B | 922M |
| Minority interests | 0 | 0 | 0 | -19M |
| Preferred stock dividends | — | — | — | — |